340b Drug Pricing Program Eligibility Cases in Second Circuit

Browse 1 340b drug pricing program eligibility cases decided by Second Circuit. AI-powered summaries, holdings, and legal analysis.

1
Cases
1
Reversed

340b Drug Pricing Program Eligibility Opinions from Second Circuit (1)

Boehringer Ingelheim Pharms., Inc. v. Dep't of Health & Hum. Servs.

2nd Cir. Rejects HHS Interpretation of 340B Drug Program Rules

Second Circuit · 2025-08-07 · Reversed · Impact: 75/100

Boehringer Ingelheim Pharms., Inc. v. Dep't of Health & Hum. Servs., decided by Second Circuit on August 7, 2025, resulted in a reversed outcome. The Second Circuit reviewed the Department of Health a...

Frequently Asked Questions

Q: How many 340b drug pricing program eligibility cases has Second Circuit decided?

CaseLawBrief currently tracks 1 340b drug pricing program eligibility cases from Second Circuit. This number is updated as new opinions are published.

Q: What types of outcomes occur in 340b drug pricing program eligibility cases at Second Circuit?

Outcome breakdown: Reversed: 1.

Q: Where can I find plain English summaries of 340b drug pricing program eligibility rulings from Second Circuit?

Each case page on CaseLawBrief includes an AI-generated plain English summary, key holdings, and legal analysis. Click any case above to read its full analysis.

Explore More

All Second Circuit Cases All 340b Drug Pricing Program Eligibility Cases All Courts All Topics Search